Multivocal review identifies failure modes and introduces Minimum Viable Factory Recovery in manufacturing systems, emphasizing interdependencies.
Ransomware recovery in critical manufacturing infrastructure is not only a backup-restoration problem. Production capability depends on coupled information-technology, operational-technology, physical-process, quality, logistics, identity, and supplier systems. After ransomware, a plant may rebuild servers yet remain unable to schedule work, authenticate operators, trust engineering workstations, release product, reconnect OT assets, or coordinate suppliers. This paper reframes manufacturing ransomware recovery as a critical-infrastructure continuity and interdependency problem. We conduct a PRISMA-guided multivocal review of academic literature, standards and government guidance, threat frameworks, public incident material, and verified full-text/source-page evidence anchors. The review identifies nine source-supported recovery failure modes: dependency blindness, untrusted restore point and backup over-trust, identity trust collapse, lack of proof-of-recovery, unsafe OT reconnection, segmentation assumption failure, capability mismatch, unmanaged degraded operation, and supplier dependency failure. We then introduce Minimum Viable Factory Recovery (MVF Recovery): the smallest operationally acceptable, trusted, and meaningful production capability that can be resumed under current dependency, evidence, identity, data, network, OT, quality-release, and supplier constraints. MVF Recovery is an analytical decision-support objective rather than a claim of full recovery, implementation, formal safety certification, or regulatory authorization. The taxonomy and MVF construct require independent empirical validation, and the paper derives a recovery lifecycle and benchmarking directions as secondary outputs. The contribution is an evidence-calibrated foundation for capability-centric ransomware recovery in critical manufacturing infrastructure.
No takes yet. Share an insight, caveat, or question.
A 2026 study studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: